Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitis.

[1]  Tariq Ahmad,et al.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 , 2011, Nature Genetics.

[2]  Suhua Chang,et al.  i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study , 2010, Nucleic Acids Res..

[3]  D. Hommes,et al.  Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease , 2009, Inflammatory bowel diseases.

[4]  R. Gearry,et al.  Perianal Disease Predicts Changes in Crohn's Disease Phenotype—Results of a Population-Based Study of Inflammatory Bowel Disease Phenotype , 2008, The American Journal of Gastroenterology.

[5]  A. Theodoridou,et al.  Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease , 2008, BMC gastroenterology.

[6]  David J. Spiegelhalter,et al.  Use of the false discovery rate when comparing multiple health care providers. , 2008, Journal of clinical epidemiology.

[7]  A. Di Sabatino,et al.  Matrix metalloproteinase‐3 production by gut IgG plasma cells in chronic inflammatory bowel disease , 2008, Inflammatory bowel diseases.

[8]  A. C. Pereira,et al.  Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. , 2007, Cancer research.

[9]  D. Hommes,et al.  Role of matrix metalloproteinase,tissue inhibitor of metalloproteinase and tumor necrosis factor-α single nucleotide gene polymorphisms in inflammatory bowel disease , 2007 .

[10]  P. Garg,et al.  Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane? , 2007, Inflammatory bowel diseases.

[11]  C. Dietrich,et al.  Enhanced expression of MMP‐7 and MMP‐13 in inflammatory bowel disease: A precancerous potential? , 2006, Inflammatory bowel diseases.

[12]  A. Sabatino,et al.  Role of Macrophage Metalloelastase in Gut Inflammation , 2006, Annals of the New York Academy of Sciences.

[13]  Bradley M. Hemminger,et al.  TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits , 2006, Bioinform..

[14]  A. Andicoechea,et al.  Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease , 2006, Scandinavian journal of gastroenterology.

[15]  G. Abecasis,et al.  A note on exact tests of Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.

[16]  T. Joh,et al.  IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. , 2005, Cytokine.

[17]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[18]  G. Dougan,et al.  Impaired Immunity to Intestinal Bacterial Infection in Stromelysin-1 (Matrix Metalloproteinase-3)-Deficient Mice1 , 2004, The Journal of Immunology.

[19]  S. Fisher,et al.  Transmission disequilibrium test of stromelysin-1 gene variation in relation to Crohn’s disease , 2004, Journal of Medical Genetics.

[20]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[21]  T. Kirkegaard,et al.  Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn’s disease , 2004, Gut.

[22]  J. Strong,et al.  MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[23]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[24]  S. Lange,et al.  Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.

[25]  S. Rosewicz,et al.  Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease , 2000, Gut.

[26]  J. Belaiche,et al.  Increased production of matrix metalloproteinase‐3 and tissue inhibitor of metalloproteinase‐1 by inflamed mucosa in inflammatory bowel disease , 2000, Clinical and experimental immunology.

[27]  A. Evans,et al.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. , 1999, Circulation.

[28]  W D Plummer,et al.  Power and sample size calculations for studies involving linear regression. , 1998, Controlled clinical trials.

[29]  J. Gusella,et al.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. , 1998, Cancer research.

[30]  U. Saarialho-Kere,et al.  Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers , 1998, Archives of Dermatological Research.

[31]  J. Kere,et al.  Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. , 1998, The American journal of pathology.

[32]  P. Sasieni.  From genotypes to genes: doubling the sample size. , 1997, Biometrics.

[33]  H. Nagase.  Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.

[34]  Y. Shoenfeld,et al.  Smoking and Immunity: an Additional Player in the Mosaic of Autoimmunity , 1997, Scandinavian journal of immunology.

[35]  S. Werner,et al.  Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. , 1996, The Biochemical journal.

[36]  A. Henney,et al.  Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression* , 1996, The Journal of Biological Chemistry.

[37]  M. Karjalainen‐Lindsberg,et al.  Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. , 1996, The American journal of pathology.

[38]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[39]  H. Birkedal‐Hansen,et al.  Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. , 1994, The Journal of clinical investigation.

[40]  L. Staiano‐Coico,et al.  Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. , 1988, Journal of immunology.

[41]  P. Holt.  Immune and inflammatory function in cigarette smokers. , 1987, Thorax.

[42]  C. G. Becker,et al.  Effects of tobacco glycoprotein (TGP) on the immune system. III. The effect of aging on the mitogenic response of human peripheral blood lymphocytes to TGP. , 1987, Cellular immunology.

[43]  I. Căruntu,et al.  Matrix metalloproteinases involvement in pathologic conditions. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[44]  T. Salo,et al.  Gelatinase A (MMP-2), Collagenase-2 (MMP-8), and Laminin-5 γ2-Chain Expression in Murine Inflammatory Bowel Disease (Ulcerative Colitis) , 2004, Digestive Diseases and Sciences.

[45]  D. van den Boom,et al.  MALDI-TOF mass spectrometry-based SNP genotyping. , 2003, Methods in molecular biology.

[46]  Charles R Cantor,et al.  The use of MassARRAY technology for high throughput genotyping. , 2002, Advances in biochemical engineering/biotechnology.

[47]  T. Reunala,et al.  Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1, and laminin-5 in experimentally induced dermatitis herpetiformis lesions. , 1997, The Journal of investigative dermatology.

[48]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[49]  L. Matrisian,et al.  Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.

[50]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.